The NAD+ Mouse Project has ended in a record-breaking amount raised for a research project so far on Lifespan.io. The campaign ended yesterday after having raised a total of $75,285 and smashing three stretch goals!
An amazing 321 people backed the campaign and they will get to enjoy a range of great donor rewards and know that they have been a part of launching a great experiment. Thanks to their help the researchers will now be able to test if NMN has potential as an anti-aging drug.
We are both humbled and so very grateful for the generous support of the NAD mouse project. As the excitement and potential of the NAD longevity field continues to grow, we can’t wait to see what we learn and report to our supporters about what NMN can do. – Dr. David Sinclair
The experiment will launch soon and will see the researchers begin a two-year lifespan study of naturally aging wild-type mice and how the NMN molecule influences the aging processes. This will be the first time that researchers collect long-term data in regularly aging mice instead of progeric mice that are designed to age faster.
During the two-year study, information will be gathered about physical health, behavior, and cognitive ability. MRI data will also be collected, and it will give valuable insight into body composition and the lean-to-fat ratio in the mice. End-of-life pathology studies will also be conducted to find out how the mice ultimately died, and cancer incidence will also be assessed.
Without a doubt, the quality and amount of data being collected could tell us a great deal about the long-term effects of NMN on aging and health, and this project is an example of how we as a community can have an impact on the progress of aging research. We would like to thank everyone who supported the project, including donors and everyone who helped to share this project and inform others about it. Together, we did it!